Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Cirrhosis

Free Subscription 02.03.2026 1 Clin Res Hepatol Gastroenterol 3 Gastroenterology 1 Hepatology 4 J Gastroenterol 1 Lancet

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin Res Hepatol Gastroenterol

1. ONAY M, Heilani M, Gulia C, Matthias C, et al
   Sequential Anticoagulation with LMWH and DOACs in Cirrhotic Portal Vein Thrombosis.
   Clin Res Hepatol Gastroenterol. 2026 Feb 23:102792.
   PubMed         Abstract available
   
   

   
   Gastroenterology

2. HIRODE G, Zangneh HF, Cerocchi O, Khalili K, et al
   Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial.
   Gastroenterology. 2026 Jan 20:S0016-5085(25)05993.
   PubMed         Abstract available
   
   
3. WANG M, Chen F, Gao J, Liu Q, et al
   Clusterin Drives Fiber Endocytosis by Mesothelial Cells to Resolve Liver Fibrosis.
   Gastroenterology. 2026;170:569-583.
   PubMed         Abstract available
   
   
4. KIM NJ, Li M, Vutien P, Mecham B, et al
   Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening.
   Gastroenterology. 2025 Nov 14:S0016-5085(25)05906.
   PubMed         Abstract available
   
   

   
   Hepatology

5. HAGHNEJAD V, Burke L, El Ouahabi S, Parker R, et al
   Prediction models for liver decompensation in compensated advanced chronic liver disease: A systematic review.
   Hepatology. 2026;83:530-551.
   PubMed         Abstract available
   
   

   
   J Gastroenterol

6. LIU J, Jia T
   Letter to the editor to ''Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis''.
   J Gastroenterol. 2026 Feb 24. doi: 10.1007/s00535-026-02375.
   PubMed        
   
   
7. SHEN L, Lv T, Li S, Chen S, et al
   Factors associated with recompensation and criteria for etiological suppression in patients with primary biliary cholangitis.
   J Gastroenterol. 2026 Jan 13. doi: 10.1007/s00535-025-02342.
   PubMed         Abstract available
   
   
8. MYOJIN Y, Hikita H
   Growth differentiation factor 15: from stress response to clinical utility in chronic liver diseases.
   J Gastroenterol. 2026;61:117-130.
   PubMed         Abstract available
   
   
9. ZHANG L, Zhao X, Song L, Xiang H, et al
   Paired liver-spleen high-frequency ultrasound deep learning network for full-stage liver fibrosis classification and clinical benefit compared with 2D-SWE in chronic hepatitis B cohort: a prospective multicenter study.
   J Gastroenterol. 2026;61:184-194.
   PubMed         Abstract available
   
   

   
   Lancet

10. NOUREDDIN M, Kowdley KV, Odrljin T, Bain G, et al
    Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2026 Feb 5:S0140-6736(25)02276-7. doi: 10.1016/S0140-6736(25)02276.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum